These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 4031647
1. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography. Batta AK, Shefer S, Batta M, Salen G. J Lipid Res; 1985 Jun; 26(6):690-8. PubMed ID: 4031647 [Abstract] [Full Text] [Related]
2. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid. Batta AK, Salen G, Shefer S, Tint GS, Batta M. J Lipid Res; 1987 Aug; 28(8):1006-12. PubMed ID: 3668385 [Abstract] [Full Text] [Related]
3. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis. Shimazu K, Kuwabara M, Yoshii M, Kihira K, Takeuchi H, Nakano I, Ozawa S, Onuki M, Hatta Y, Hoshita T. J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361 [Abstract] [Full Text] [Related]
4. Synthesis and structure of 26 (or 27)-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,24S,25 xi-pentol isolated from the urine and feces of a patient with sitosterolemia and xanthomatosis. Dayal B, Tint GS, Toome V, Batta AK, Shefer S, Salen G. J Lipid Res; 1985 Mar; 26(3):298-305. PubMed ID: 2985722 [Abstract] [Full Text] [Related]
5. Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis. Koopman BJ, Wolthers BG, van der Molen JC, Waterreus RJ. Clin Chim Acta; 1985 Oct 31; 152(1-2):115-22. PubMed ID: 4053393 [Abstract] [Full Text] [Related]
6. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands. Koopman BJ, Wolthers BG, van der Molen JC, van der Slik W, Waterreus RJ, van Spreeken A. J Inherit Metab Dis; 1988 Oct 31; 11(1):56-75. PubMed ID: 3128689 [Abstract] [Full Text] [Related]
7. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26. Salen G, Shefer S, Tint GS, Nicolau G, Dayal B, Batta AK. J Clin Invest; 1985 Aug 31; 76(2):744-51. PubMed ID: 4031069 [Abstract] [Full Text] [Related]
8. Familial giant cell hepatitis with low bile acid concentrations and increased urinary excretion of specific bile alcohols: a new inborn error of bile acid synthesis? Clayton PT, Casteels M, Mieli-Vergani G, Lawson AM. Pediatr Res; 1995 Apr 31; 37(4 Pt 1):424-31. PubMed ID: 7596681 [Abstract] [Full Text] [Related]
9. Determination of the glucurono-conjugated position in bile alcohol glucuronides present in a patient with cerebrotendinous xanthomatosis. Kuramoto T, Suemura Y, Kihira K, Hiraoka T, Hoshita T. Steroids; 1995 Oct 31; 60(10):709-12. PubMed ID: 8539780 [Abstract] [Full Text] [Related]
10. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. Wolthers BG, Volmer M, van der Molen J, Koopman BJ, de Jager AE, Waterreus RJ. Clin Chim Acta; 1983 Jun 30; 131(1-2):53-65. PubMed ID: 6883710 [Abstract] [Full Text] [Related]
11. Identifications of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23 beta-tetrol, 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 alpha-tetrol, and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 beta-tetrol in cerebrotendinous xanthomatosis. Yasuhara M, Kuramoto T, Hoshita T, Itoga E, Kito S. Steroids; 1978 Mar 30; 31(3):333-45. PubMed ID: 663972 [Abstract] [Full Text] [Related]
12. Bile acids and bile alcohols in a child with hepatic 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency: effects of chenodeoxycholic acid treatment. Ichimiya H, Egestad B, Nazer H, Baginski ES, Clayton PT, Sjövall J. J Lipid Res; 1991 May 30; 32(5):829-41. PubMed ID: 2072042 [Abstract] [Full Text] [Related]
13. Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment. Koopman BJ, Wolthers BG, van der Molen JC, Nagel GT, Waterreus RJ, Oosterhuis HJ. Clin Chim Acta; 1984 Sep 15; 142(1):103-11. PubMed ID: 6478619 [Abstract] [Full Text] [Related]
14. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis. Batta AK, Salen G, Tint GS. Metabolism; 2004 May 15; 53(5):556-62. PubMed ID: 15131757 [Abstract] [Full Text] [Related]
15. Identification of (23S)-5 alpha-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in urine of patients with cerebrotendinous xanthomatosis. Kihira K, Fukuda K, Kuramoto T, Kuriyama M, Fujiyama J, Osame M, Hoshita T. Steroids; 1991 Sep 15; 56(9):464-8. PubMed ID: 1805458 [Abstract] [Full Text] [Related]
16. Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis. Hoshita T, Yasuhara M, Une M, Kibe A, Itoga E, Kito S, Kuramoto T. J Lipid Res; 1980 Nov 15; 21(8):1015-21. PubMed ID: 7462799 [Abstract] [Full Text] [Related]
17. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis. Salen G, Shefer S, Cheng FW, Dayal B, Batta AK, Tint GS. J Clin Invest; 1979 Jan 15; 63(1):38-44. PubMed ID: 762246 [Abstract] [Full Text] [Related]
19. Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis. Salen G, Batta AK, Tint GS, Shefer S. Metabolism; 1994 Aug 15; 43(8):1018-22. PubMed ID: 8052141 [Abstract] [Full Text] [Related]
20. Identification of bile alcohols in human bile. Kuroki S, Shimazu K, Kuwabara M, Une M, Kihira K, Kuramoto T, Hoshita T. J Lipid Res; 1985 Feb 15; 26(2):230-40. PubMed ID: 3989382 [Abstract] [Full Text] [Related] Page: [Next] [New Search]